U.S. Telecom Services and Carriers Stock News

BeOne Medicines recently announced positive topline results from a Phase 1/2 study of sonrotoclax, its investigational BCL2 inhibitor, in adult patients with relapsed or refractory mantle cell lymphoma who had already undergone Bruton's tyrosine kinase inhibitor and anti-CD20 treatment. This milestone strengthens BeOne’s hematology portfolio, highlights ongoing regulatory progress, and supports efforts to address high unmet needs in aggressive B-cell malignancies. We’ll assess how these...

Rapport Therapeutics announced positive topline results from its Phase 2a clinical trial of RAP-219 in patients with drug-resistant focal onset seizures, meeting primary and secondary efficacy endpoints with high statistical significance and a strong safety profile. The study reported that 24% of participants experienced seizure freedom during the 8-week treatment period, an outcome that highlights significant potential for improving quality of life in this hard-to-treat patient group. We'll...

If you have been tracking Affirm Holdings (AFRM), the company’s latest earnings announcement might just make you rethink your outlook. Affirm reported a jump in annual revenue and, more notably, turned a profit after a year of significant net losses. This earnings turnaround, with growth that outpaced expectations, has put Affirm right back into the spotlight for investors considering where the company’s value could go from here. The news sent a wave through the market, and it comes on the...

Fastly (NYSE:FSLY) is making headlines as the company shakes up its top leadership, announcing Kip Compton as the new CEO and welcoming Richard Wong as CFO. This double appointment comes on the heels of an upgrade from Craig-Hallum, which points to stronger financial performance and encouraging signs in Fastly’s core markets. For investors, a new executive team during a corporate transformation is often a catalyst that sparks fresh attention and debate about the direction and value of the...

If you’re trying to decide what to do with shares of Concentrix (CNXC), you picked an active moment. The company was just named a Market Leader in HFS Research's 2025 Digital Marketing and Sales Services Horizon report, outshining 13 global peers. This distinction highlights Concentrix’s rollout of proprietary AI tools, credited with slashing information search time for a Fortune 500 client and driving major revenue gains elsewhere. It is exactly the type of recognition that puts a company’s...

Duolingo recently unveiled major product updates at its annual Duocon conference, introducing new video call features, an expanded Energy System, and non-language learning offerings designed to boost user engagement as daily active user growth slows and AI competition increases. Analyst sentiment surrounding Duolingo remains positive, with the company's focus on AI-driven innovation and strong earnings performance helping to sustain optimism despite intensifying competition and near-term...

If you’re wondering whether to take action on Ollie’s Bargain Outlet Holdings (OLLI) right now, you’re not alone. The stock jumped into the spotlight after the company released second-quarter results showing growth in both sales and net income compared to last year. In addition, management surprised the market by raising its full-year sales and operating income targets, offering a more optimistic view for the coming months. These financial updates appear to have energized investors. Over the...

If you own or are watching BXP (BXP), the company’s latest move is impossible to ignore. At its recent Investor Day, the management announced a significant 29% cut to its quarterly dividend. This decision is designed to bolster its finances by freeing up around $50 million each quarter. While dividend cuts typically raise concerns, BXP’s strategy is to funnel that cash into fresh development projects and tighten up its balance sheet, aiming for stronger long-term prospects rather than just...

On August 28, 2025, Redwire Corporation announced it was awarded a NASA single award, indefinite-delivery/indefinite-quantity (IDIQ) contract with a US$25 million ceiling over five years, including a recent US$2.5 million task order to support ISS-based drug development using its PIL-BOX technology. This NASA contract builds on Redwire’s role in providing biotechnology facilities and on-orbit operations for the International Space Station, highlighting its expanding presence in the growing...

Marex Group plc participated in the Barclays 23rd Annual Global Financial Services Conference in New York on September 8, 2025, with Group CEO Ian Theo Lowitt addressing attendees amid heightened scrutiny of the company's financial disclosures. This event follows multiple law firm investigations into allegations of off-balance-sheet entities and misleading reporting, increasing regulatory attention on Marex’s governance and transparency practices. We’ll examine how mounting legal and...

If you’re watching Certara (CERT) for signs of a turnaround, the latest launch of Pinnacle 21 Enterprise Plus is worth your attention. This product promises a major shift in how clinical and statistical programmers handle complex regulatory data submissions, an area that has been bogged down by manual processes and inefficiencies for years. With the company touting up to a 50% reduction in time spent drafting mapping specifications, this move tackles a core pain point for its key customers...

If you’ve been keeping an eye on Northwest Natural Holding (NWN), the recent move in its share price may have caught your attention and raised some questions. There hasn’t been any single big announcement lighting up the headlines, but shifts like this often prompt investors to dig a bit deeper. Is it a signal that something is brewing beneath the surface, or just typical market noise? With long-term utility stocks like NWN, these moments can be easy to overlook. Sometimes, even quieter...

Ionis Pharmaceuticals recently announced that its experimental drugs achieved major milestones, including the FDA granting Breakthrough Therapy designation to ION582 for Angelman syndrome after promising early trial results, and positive Phase 3 outcomes for olezarsen in severe hypertriglyceridemia with statistically significant reductions in triglycerides and acute pancreatitis events. These achievements underscore Ionis’s advancing RNA-targeted pipeline and highlight expanding momentum in...

In the past week, MP Materials presented at two major industry conferences and announced a multi-billion-dollar agreement with the U.S. Department of Defense, alongside a US$500 million investment from Apple supporting its rare-earth operations at Mountain Pass Mine. These announcements highlight how global trade restrictions have elevated the company's role in establishing a secure U.S. supply of neodymium, essential for electronics and defense manufacturing. We'll explore how the...

If you’ve been following IREN (NasdaqGS:IREN) lately, you might have noticed a surge in investor buzz around the stock. That uptick is tied to two key events: the company just released quarterly results showing major jumps in both revenue and earnings, and there is a leadership shake-up as IREN announced a new chief financial officer with deep experience in global capital markets. For investors weighing next steps, these changes signal that strategic and financial priorities may be shifting...

BioNTech and Pfizer recently announced positive results from a Phase 3 trial of their LP.8.1-adapted COVID-19 vaccine, showing a robust immune response in high-risk adult groups and reinforcing the FDA’s recent approval for the 2025–2026 formula. BioNTech also reported successful late-stage trial outcomes for its breast cancer treatment, highlighting ongoing momentum in diversifying its oncology pipeline beyond infectious disease vaccines. We’ll now consider how BioNTech’s recent clinical...

If you’ve been watching SharpLink Gaming (SBET) lately, you know there’s no shortage of headlines to digest. The company just kicked off a $1.5 billion share buyback program and announced a massive boost in Ethereum holdings, now counting billions in digital assets. If that wasn’t enough, they have brought in Joseph Chalom from BlackRock as Co-CEO, all of which are signals that management believes in a bold future. But with these assertive moves, investors are left wondering if confidence is...

If you’re looking at Golar LNG (NasdaqGS:GLNG) and wondering what’s behind the recent wave of interest, you’re not alone. The catalyst this time is new commentary centering on the company’s deep backlog of contracted floating LNG (FLNG) projects and a fresh MKII contract, both of which come with the promise of commodity-linked upside. Investors are also taking note of unique contract structures that essentially function like a long-term call option on LNG prices, putting a spotlight on...

Prairie Operating Co. recently provided a comprehensive operational update on its 2025 drilling and completion schedule, reporting successful initial production from recently acquired and developed wells as well as progress on multiple Niobrara and Codell pad projects. The company’s introduction of its first U-turn wells and the achievement of strong early well results have increased attention on operational efficiencies and anticipated production growth milestones. We’ll examine how...

Frontline plc has recently announced a US$0.36 per share dividend for the second quarter of 2025, following its release of Q2 earnings showing sales of US$480.08 million and net income of US$77.54 million, both down from a year ago. Despite the year-on-year declines, management emphasized sequential improvements in time charter equivalent rates and pointed to a positive outlook in the tanker market due to limited new vessel supply and shifting global trade flows. We'll examine how the...

Powell Industries (POWL) just made a move that has investors talking: a $12.4 million investment to boost production capacity. This is not just another routine expansion. Management’s decision here signals real conviction in the company’s future demand outlook, even as the market digests fresh concerns over U.S. tariffs and higher Treasury yields. Against this backdrop of uncertainty, Powell’s commitment to long-term growth stands out and may reshape expectations for what is possible in the...

Crown Castle Inc. recently participated in the Goldman Sachs Communacopia + Technology Conference on September 11, 2025, in San Francisco, where Executive VP & CFO Sunit S. Patel was a featured speaker. This event provided industry stakeholders with an opportunity to hear directly from Crown Castle leadership on company strategy, operational outlook, and capital allocation plans amid significant changes in its business focus. We’ll explore how Crown Castle’s public strategy discussion at...

If you have been following IDEAYA Biosciences (IDYA), you have likely noticed a sharp uptick in attention after a series of clinical data releases. Over the past week, the company presented encouraging results for three different programs: IDE849 for small cell lung cancer, darovasertib in primary uveal melanoma, and IDE397 in combination with Trodelvy in late-line urothelial cancer. Each update points to promising efficacy and manageable safety. These are key details that matter when...

In August 2025, CoreWeave announced it finalized a new lease agreement for an additional 150MW at Applied Digital’s Polaris Forge 1 Campus in North Dakota, raising Applied Digital’s total anticipated contracted lease revenue to about US$11 billion from major AI infrastructure clients. This lease agreement highlights Applied Digital’s accelerated pivot to powering AI technologies and marks growing industry recognition by specialized ETF providers targeting the sector’s future. We’ll now...